Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

L162389

L162389 is an orally bioavailable, non-selective angiotensin II receptor antagonist that binds both AT1 and AT2 subtypes and induces phosphatidylinositol turnover. It is a research tool used in vitro and in vivo to study the renin-angiotensin system, cardiovascular physiology, and receptor signaling pathways.

Product Specifications

CAS Number

169281-53-2

Product Name Alternative

Angiotensin Receptor, angiotensin AT1 receptor, L 162389, L162389, L-162389

Field of Research

Metabolism Research

Purity

99.11% (May vary between batches)

Smiles

O=C (OCCCC) NS (=O) (=O) C=1C=CC (=CC1C2=CC=C (C=C2) CN3C4=NC (=CC (=C4N=C3CC) C) C) CCC

Molecular Formula

C31H38N4O4S

Molecular Weight

562.72

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

ALV-05-151-02
orb3181131-01 50 mg

ALV-05-151-02

Sign In for Pricing
View Details
ALV-05-151-02
orb3181131-02 10 mg

ALV-05-151-02

Sign In for Pricing
View Details
Recombinant Torque teno virus Uncharacterized ORF2/4 protein (ORF2/4, ORF3)
MBS1318687-01 0.05 mg (E-Coli)

Recombinant Torque teno virus Uncharacterized ORF2/4 protein (ORF2/4, ORF3)

Sign In for Pricing
View Details
Recombinant Torque teno virus Uncharacterized ORF2/4 protein (ORF2/4, ORF3)
MBS1318687-02 0.05 mg (Yeast)

Recombinant Torque teno virus Uncharacterized ORF2/4 protein (ORF2/4, ORF3)

Sign In for Pricing
View Details
Recombinant Torque teno virus Uncharacterized ORF2/4 protein (ORF2/4, ORF3)
MBS1318687-03 0.2 mg (E-Coli)

Recombinant Torque teno virus Uncharacterized ORF2/4 protein (ORF2/4, ORF3)

Sign In for Pricing
View Details
Recombinant Torque teno virus Uncharacterized ORF2/4 protein (ORF2/4, ORF3)
MBS1318687-04 0.05 mg (Baculovirus)

Recombinant Torque teno virus Uncharacterized ORF2/4 protein (ORF2/4, ORF3)

Sign In for Pricing
View Details